Investment Firm
Overview
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Aug 09, 2016
Series C
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
7
Iconic Therapeutics raised $10000000 on 2016-08-09 in Series C
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Company Funding History
12
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Apr 30, 2007 | Venture Round - Iconic Therapeutics | 1 | - | 1.3M |
Aug 22, 2011 | Venture Round - Iconic Therapeutics | 1 | - | undefined |
Apr 16, 2014 | Series B - Iconic Therapeutics | 3 | - | 20.0M |
Jan 17, 2009 | Venture Round - Iconic Therapeutics | 2 | - | 2.5M |
Recent Activity
There is no recent news or activity for this profile.